Windham Venture Partners

@windhamvp

January 24, 2018

Neuspera™ Medical Announces Initial Close of $26M Series B Equity Financing

SAN JOSE, Calif., Jan. 24, 2018 /PRNewswire/ — Neuspera Medical Inc., a clinical stage, private venture capital backed neuromodulation company, today announced the initial closing of their Series B equity … Continued

January 04, 2018

Personal Genome Diagnostics Raises $75 Million to Bring Regulated IVD Genomic Tests to Cancer Patients Worldwide

BALTIMORE /PRNewswire/ — Personal Genome Diagnostics Inc. (PGDx) today announced a $75 millionSeries B financing co-led by new investor Bristol-Myers Squibb and existing investor New Enterprise Associates (NEA). Other new and existing … Continued

Archives

© 2024 Windham Venture Partners 500 Fifth Avenue, Suite 3600, NY, NY 10110